[Preprint] RECOVERY trial: Azithromycin does not improve outcomes in hospitalized patients with COVID-19

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv

News release: RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19

Commentary: Expert reaction to preprint from the RECOVERY trial on the antibiotic azithromycin in patients hospitalised with COVID-19, reporting no benefit – Science Media Centre

Commentary on Twitter

New RECOVERY result. In patients hospitalised with COVID-19, azithromycin did not provide any clinical benefit. 28 day mortality (19% vs 19%) (rate ratio 1·00; 95% confidence interval [CI] 0·90-1·12; p=0·99). No effect on secondary outcomes either.https://t.co/PTklz40WKr pic.twitter.com/NCzvRIND0S

— Peter Horby (@PeterHorby) December 14, 2020